Listed

Colgate Palmolive Co: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Oct 28, 2022 and accepted by EDGAR at Oct 28, 2022, 08:40 ET.

Share

Management's discussion and analysis

As filed, 1,951 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On March 10, 2022, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2022 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended September 30, 2022:

Month Total Number of Shares Purchased(1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
July 1 through 31, 2022 — $— — $4,489
August 1 through 31, 2022 4,356 $82.17 — $4,489
September 1 through 30, 2022 1,522,662 $74.45 1,460,400 $4,380
Total 1,527,018 $74.47 1,460,400

(1) Includes share repurchases under the 2022 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 66,618 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of September 30, 2022.

Risk factors

As filed, 294 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors disclosed in “Risk Factors” in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 other than as set forth in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$4.46bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$13.34bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$1.91bnus-gaap:CostOfRevenue
Cost of revenue9 months2022-01-01 to 2022-09-30$5.66bnus-gaap:CostOfRevenue
Gross profit3 months2022-07-01 to 2022-09-30$2.55bnus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-09-30$7.67bnus-gaap:GrossProfit
Selling, general and administrative3 months2022-07-01 to 2022-09-30$1.63bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-09-30$4.93bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-01 to 2022-09-30$947.0mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30$2.69bnus-gaap:OperatingIncomeLoss
Income tax3 months2022-07-01 to 2022-09-30$210.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$604.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30$618.0mus-gaap:NetIncomeLoss
Net income9 months2022-01-01 to 2022-09-30$1.78bnus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30$0.74us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$2.12us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30$0.74us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$2.12us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-30838,500,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-30840,400,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30$1.88bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-09-30$475.0mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases9 months2022-01-01 to 2022-09-30$895.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-09-30$938.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$5.28bnus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$16.29bnus-gaap:Assets
Current liabilitiesAt period end2022-09-30$4.49bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-09-30$15.23bnus-gaap:Liabilities
Long-term debtAt period end2022-09-30$8.22bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-09-30$13.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-09-30$622.0mus-gaap:StockholdersEquity
Shares outstandingAt period end2022-09-30835,214,210 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000021665-22-000027. Last ingested by Listed: Nov 13, 2026, 16:05 ET. Listed shows no prices and gives no investment advice.